Search

Search Constraints

You searched for: Author/Creator Chlibek, Roman

Search Results

1. 1173Long-term Immunogenicity and Safety of an Investigational Herpes Zoster Subunit Vaccine in Older Adults. (December 2014)

3. Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials. Issue 43 (8th October 2019)

4. Erratum to: Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults ≥50 Years of Age. (20th November 2020)

5. Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older. (26th February 2018)

6. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations. (June 2014)

7. Immunization of high-risk paediatric populations: Central European Vaccination Awareness Group recommendations. (June 2014)

9. Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults. Issue 6 (3rd February 2016)

10. Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials. Issue 12 (2nd December 2019)